|
Index of reports
> Cases resulting in death (15)
> Cases with Hepatic Failure (4)
Below is the selection of adverse event reports related to Amaryl (Glimepiride) that includes cases resulting in death where reactions include hepatic failure.
Adverse event in 87 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-23
Patient: 87 year old female, weighing 35.0 kg (77.0 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Coagulopathy, Cholestasis, Coma, Hepatic Failure, Gastrointestinal Tube Insertion, Liver Disorder, Hepatic Encephalopathy, Subdural Haematoma, Malaise, Gamma-Glutamyltransferase Increased, Cholecystitis, Gallbladder Disorder, Prothrombin Time Ratio Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Tremor, Cholelithiasis, Anorexia, Aspartate Aminotransferase Increased, Gallbladder Polyp
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-04-01
End date: 2007-05-17
Aspirin
Dosage: 100 mg/day
Administration route: Oral
Indication: Angina Pectoris
Start date: 2007-04-01
End date: 2007-05-26
Diovan
Dosage: 40 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2006-06-14
End date: 2007-05-23
Norvasc
Dosage: 2.5 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 1999-05-01
End date: 2007-05-25
Other drugs received by patient: Roxatidine Acetate HCL; Nateglinide; Triazolam; Lisinopril; Lisinopril
Adverse event in 77 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-05-15
Patient: 77 year old female, weighing 27.1 kg (59.6 pounds)
Adverse reactions / side effects: Hepatic Failure, Hepatitis Fulminant
Adverse event resulted in: death
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-20
End date: 2007-03-21
Amaryl
Administration route: Oral
Start date: 2007-03-22
End date: 2007-03-24
Myslee
Administration route: Oral
Start date: 2006-12-08
End date: 2007-03-24
Myslee
Administration route: Oral
End date: 2006-11-01
Other drugs received by patient: Asasion; Pelex; Thyradin; Innolet 30R; Pirolacton; Nitrous; Sennoside
Adverse event in 77 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-04-23
Patient: 77 year old female, weighing 27.1 kg (59.6 pounds)
Adverse reactions / side effects: Hepatic Failure, Hepatitis Fulminant
Adverse event resulted in: death
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-20
End date: 2007-03-21
Amaryl
Administration route: Oral
Start date: 2007-03-22
End date: 2007-03-24
Myslee
Administration route: Oral
Start date: 2006-12-08
End date: 2007-03-24
Myslee
Administration route: Oral
End date: 2006-11-01
Other drugs received by patient: Asasion; Pelex; Thyradin; Innolet 30R; Pirolacton; Nitrous; Sennoside
Adverse event in 77 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-04-19
Patient: 77 year old female, weighing 27.1 kg (59.6 pounds)
Adverse reactions / side effects: Nasopharyngitis, Pruritus, Hepatic Failure, Nasal Congestion, Depressed Level of Consciousness, Pharyngolaryngeal Pain, Diabetes Mellitus Inadequate Control, Hepatitis Fulminant
Adverse event resulted in: death
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-20
End date: 2007-03-21
Amaryl
Administration route: Oral
Start date: 2007-03-22
End date: 2007-03-24
Myslee
Administration route: Oral
Indication: Insomnia
Start date: 2006-12-08
End date: 2007-03-24
Myslee
Administration route: Oral
End date: 2006-11-01
Other drugs received by patient: Asasion; Pelex; Thyradin; Innolet 30R; Pirolacton; Nitrous; Sennoside
|
